1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT plus PCV IN HIGH RISK LOW-GRADE GLIOMAS Conference

Bell, Erica H, Zhang, Peixin, Shaw, Edward G et al. (2016). 1p/19q CO-DELETION STATUS PREDICTS SURVIVAL OUTCOMES IN NRG ONCOLOGY/RTOG 9802: A PHASE III TRIAL OF RT VS RT plus PCV IN HIGH RISK LOW-GRADE GLIOMAS . NEURO-ONCOLOGY, 18 106-106.

International Collaboration

cited authors

  • Bell, Erica H; Zhang, Peixin; Shaw, Edward G; Buckner, Jan C; Barger, Geoffrey R; Coons, Stephen W; Bullard, Dennis E; Mehta, Minesh P; Gilbert, Mark R; Brown, Paul D; Stelzer, Keith J; McElroy, Joseph P; Fleming, Jessica; Chakraborty, Arup; Becker, Aline Paixao; Aldape, Kenneth D; Brachman, David G; Murtha, Albert D; Schultz, Christopher J; Johnson, David; Gertler, Stanley Z; Laack, Nadia N; Werner-Wasik, Maria; Crocker, Ian R; Chakravarti, Arnab

sustainable development goals

authors

date/time interval

  • November 17, 2016 -

publication date

  • November 1, 2016

webpage

published in

keywords

  • Clinical Neurology
  • Life Sciences & Biomedicine
  • Neurosciences & Neurology
  • Oncology
  • Science & Technology

Location

  • Scottsdale, AZ

Conference

  • 21st Annual Scientific Meeting and Education Day of the Society-for-Neuro-Oncology

publisher

  • OXFORD UNIV PRESS INC

start page

  • 106

end page

  • 106

volume

  • 18